Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT05510115 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05510115
- Sponsor
- University of Colorado, Denver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2026-03-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.